Tower Hamlets student uncovers ground-breaking cancer research
AN East End student has won an award for his research into breast cancer therapy. Claudio Raimondi who is studying at the Barts and The London School of Medicine and Dentistry in Whitechapel was awarded the Emerging Investigators Poster Prize. Through
AN East End student has won an award for his research into breast cancer therapy.
Claudio Raimondi who is studying at the Barts and The London School of Medicine and Dentistry in Whitechapel was awarded the Emerging Investigators Poster Prize.
Through the Blizard Institute of Cell and Molecular Science, which is part of Queen Mary University, the PHD student has been researching a specific molecule which could be used to slow down the growth of breast cancer or prevent tumours spreading.
Claudio's project found that the molecule would be able to block the activity which triggers the process metastasis - the spread of the disease from one organ to another - which is the main cause of death in cancer patients.
You may also want to watch:
There are currently no effective treatments which exist for metastatic breast cancer.
Claudio had to give a review and a five-minute presentation before he could claim the award at the Breast Cancer Campaign research 2010 conference.
- 1 Tribute to 7th Barts Health Trust worker to die of Covid-19
- 2 The Queen lends her name to Royal London’s emergency Covid wards
- 3 Airbnb house party violence leaves police officer with broken finger
- 4 Teenager found dead in Victoria Park
- 5 Drug and alcohol abuse by Tower Hamlets parents and children soars
- 6 Driver arrested after police 'drugs patrol' stops car in Whitechapel
- 7 'We need laptops for lockdown children to learn from home’ Tower Hamlets mayor urges
- 8 Disgraceful management of the pandemic
- 9 Have you seen this 52-year-old man missing from Ilford?
He said: "It is an exciting area of research and could have significant impact for people with metastatic breast cancer
"Further work has to be accomplished in order to collect all the experimental data needed to allow the transition to clinical trials.